Cargando…
The NLRP3 Inflammasome Inhibitor Dapansutrile Attenuates Cyclophosphamide-Induced Interstitial Cystitis
Interstitial cystitis (IC)/bladder pain syndrome (BPS), hereafter referred together as IC, is a clinical syndrome characterized by sterile inflammation in the bladder. While the etiology and pathophysiology of IC remain unclear, it may involve autoimmunity in light of the significant role played by...
Autores principales: | Kiran, Sonia, Rakib, Ahmed, Singh, Udai P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205468/ https://www.ncbi.nlm.nih.gov/pubmed/35720309 http://dx.doi.org/10.3389/fimmu.2022.903834 |
Ejemplares similares
-
OLT1177 (Dapansutrile), a Selective NLRP3 Inflammasome Inhibitor, Ameliorates Experimental Autoimmune Encephalomyelitis Pathogenesis
por: Sánchez-Fernández, Alba, et al.
Publicado: (2019) -
Differential Expression of microRNAs Correlates With the Severity of Experimental Autoimmune Cystitis
por: Kumar, Vijay, et al.
Publicado: (2021) -
Role of NLRP3 inflammasome in the development of bladder pain syndrome interstitial cystitis
por: Tudrej, Karol Borys, et al.
Publicado: (2019) -
Pharmacological Inhibitors of the NLRP3 Inflammasome
por: Zahid, Ayesha, et al.
Publicado: (2019) -
CXCL10 blockade protects mice from cyclophosphamide-induced cystitis
por: Sakthivel, Senthilkumar K, et al.
Publicado: (2008)